Trial Profile
A Pharmacogenomic Exploration of Lacosamide Response
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 27 Feb 2017
Price :
$35
*
At a glance
- Drugs Lacosamide (Primary)
- Indications Epilepsy
- Focus Pharmacogenomic; Therapeutic Use
- 25 Jul 2011 New trial record